Regen BioPharma, Inc.
RGBP
$0.00
$0.00-50.00%
OTC PK
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -83.33% | 4,500.00% | 9,842.86% | -97.09% | -97.70% |
| Total Receivables | 73.48% | 89.94% | 115.91% | 163.93% | 277.08% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -33.33% | -99.61% | -99.58% | -99.15% | -94.23% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 71.52% | 36.50% | 91.49% | 17.52% | 23.33% |
|
|
|||||
| Total Current Assets | 71.52% | 36.50% | 91.49% | 17.52% | 23.33% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 53.51% | 23.88% | 70.45% | 15.63% | 20.38% |
|
|
|||||
| Total Accounts Payable | -40.06% | -69.44% | -94.28% | 3.74% | 13.09% |
| Total Accrued Expenses | 13.32% | 8.46% | 10.42% | 6.73% | 6.55% |
| Short-term Debt | -32.79% | 23.26% | -34.89% | 21.49% | 319.12% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 7.98% | 27.20% | 101.34% | 54.01% | 51.49% |
| Total Finance Division Other Current Liabilities | -14.78% | 18.10% | 21.72% | 8.73% | 5.61% |
| Total Other Current Liabilities | -14.78% | 18.10% | 21.72% | 8.73% | 5.61% |
| Total Current Liabilities | -4.24% | 16.01% | 21.89% | 12.85% | 13.43% |
|
|
|||||
| Total Current Liabilities | -4.24% | 16.01% | 21.89% | 12.85% | 13.43% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -32.79% | 23.26% | -34.89% | 21.49% | 319.12% |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -4.24% | 16.01% | 21.89% | 12.85% | 10.37% |
|
|
|||||
| Common Stock & APIC | 6.85% | 5.50% | 1.48% | 2.07% | 2.74% |
| Retained Earnings | -3.42% | -8.25% | -6.24% | -3.77% | -3.61% |
| Treasury Stock & Other | -8.69% | -8.69% | -8.69% | -- | -- |
| Total Common Equity | 5.70% | -15.74% | -20.39% | -12.77% | -10.11% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | 1,450.00% | 0.00% | 0.00% | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 1,450.00% | 0.00% | 0.00% | -- | -- |
|
|
|||||
| Total Common Equity | 5.70% | -15.74% | -20.39% | -12.77% | -10.11% |
| Total Preferred Equity | 1,450.00% | 0.00% | 0.00% | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 5.96% | -15.74% | -20.39% | -12.76% | -10.09% |
|
|
|||||